access+affordability

The drug, avacopan, which will be available under brand name Tavneos in the next few weeks, will have a wholesale price of between $150,000 and $200,000 per patient per year.

In fact, the proposed drug price negotiation program does not authorize the federal government to decide which medications people on Medicare can and cannot get and does not establish or require a particular prescription drug formulary.

A notion in the policy community is that competition between biologics and their biosimilars does not save patients and taxpayers as much as well-functioning generic competition.

Conceived at the start of the pandemic, COVAX had lofty goals, promising fair and equitable access to Covid-19 vaccines for every country worldwide, and giving them for free to the poorest.

Medicare and a host of other federal agencies are prohibited by law from accessing this kind of purchasing power.

Vancouver City Council has voted to support a federal application that would allow a "compassion club" model and provide tested drugs in the city.

When babies are born in western Kenya, where malaria is rife, many mothers are sent home from the hospital with one all-important baby gift: a bed net treated with insecticide.

The B.C. government has also announced a new provincially co-ordinated model of care for cystic fibrosis patients.

Less than a week after Merck and Ridgeback released extraordinary data on the effectiveness of experimental COVID-19 drug molnupiravir, the rush is on to lock up supplies.

'We might need to make a move if Manitoba can't make a decision quickly,' says mom of boy with cystic fibrosis.

Cancer outcomes in Australia are among the best in the world, except for those in rural and remote areas.

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available on the NHS for sickle cell disease.

Nearly a dozen state governments said they are grappling with shortages of rapid tests, which provide on-the-spot results within minutes and are crucial for COVID-19 surveillance programs.

This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests.

The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.